Literature DB >> 23207071

New horizons in breast imaging.

F Kilburn-Toppin1, S J Barter.   

Abstract

The imaging of breast cancer has undergone significant progression in recent years. A multimodality approach is often required, with ongoing developments in mammography, ultrasound, magnetic resonance and nuclear medicine all contributing to breast cancer imaging. Here we review the literature to assess how advances in well-established technologies, such as mammography, have brought added benefits both in terms of diagnostic and practical benefits, as well as allowing the application of derived technologies, such as tomosynthesis and contrast-enhanced mammography. We consider how these newer technologies may fit into clinical practice, both in terms of general population screening as well as use as problem solving tools in specific patient groups, and where the limitations for these may lie. We aim to highlight some of the promising advances in imaging that are still in earlier stages, such as magnetic resonance elastography, as well as reviewing techniques that are already becoming incorporated into clinical practice.
Copyright © 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23207071     DOI: 10.1016/j.clon.2012.10.002

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

Review 1.  Current and future trends in photoacoustic breast imaging.

Authors:  Srirang Manohar; Maura Dantuma
Journal:  Photoacoustics       Date:  2019-06-30

Review 2.  Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?

Authors:  Marianna Alunni-Fabbroni; Volkmar Müller; Tanja Fehm; Wolfgang Janni; Brigitte Rack
Journal:  Breast Care (Basel)       Date:  2014-02       Impact factor: 2.860

3.  Signs analysis and clinical assessment: phase-contrast computed tomography of human breast tumours.

Authors:  Wushuai Jian; Mingshu Wu; Hongli Shi; Liting Wang; Lu Zhang; Shuqian Luo
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

Review 4.  Critical analysis of the potential for microRNA biomarkers in breast cancer management.

Authors:  Carrie R Graveel; Heather M Calderone; Jennifer J Westerhuis; Mary E Winn; Lorenzo F Sempere
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.